New Zealand Subcommittee

ASID acknowledges and respects iwi and hapū as tangata whenua of Aotearoa and is committed to upholding the principles of Te Tiriti o Waitangi (the Treaty of Waitangi). ASID strives to activity foster a strong relationship with Māori, and to have equitable outcomes for Māori patients and their whānau in Aotearoa/New Zealand.

The ASID New Zealand Subcommittee brings together ASID’s NZ members.

The group has a keen interest in antimicrobial stewardship, a national approach to infections and health reforms. With a focus on advocacy and policy, members hold positions on national advisory groups, advising the PM and cabinet, are involved in trans Tasman research initiatives and participate in the Vaccine Alliance Aotearoa.

Following the COVID-19 pandemic, some members have been involved in Te Niwha, the Infectious Diseases Research Platform established to prepare for known and emerging disease threats in New Zealand. ASID members have presented lessons and opportunities for improvement in the research response to future infectious diseases.

The creation of Te Whatu Ora and Te Aka Whai Ora in 2022 as part of Aotearoa's health system reforms has led to ASID members becoming involved in its development.

Members:
Chair: Dr Michelle Balm
Past Chair: Dr Nigel Raymond
Treasurer: Dr Arthur Morris
Webmaster/NZBUG Moderator: Dr Richard Everts
Members: Dr Rachel Webb, Dr Kerry Read, Dr Kate Grimwade, Dr Susan Morpeth, Dr Juliet Elvy, Dr Brendan Arnold, Dr Heather Isenman.
Trainee Representative: Michael-John Fay

A NZ Scientific Meeting is held annually. The Chair is a member of the ASID Council that provides strategic input to the ASID Board.